Risk of Cardiovascular Events Associated with Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis

BACKGROUND: The cardiovascular (CV) safety of inhaled corticosteroids (ICSs) in chronic obstructive pulmonary disease (COPD) is controversial because different studies have suggested that ICSs either increase or reduce the risk of CV events in COPD patients. In this meta-analysis, we assess the CV s...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Xia, Li, Yufeng, Xu, Jianying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079461/
https://www.ncbi.nlm.nih.gov/pubmed/30123392
http://dx.doi.org/10.1155/2018/7097540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079461/
https://www.ncbi.nlm.nih.gov/pubmed/30123392
http://dx.doi.org/10.1155/2018/7097540

Ejemplares similares